Study Summary
The purpose of the study is to evaluate the safety, tolerability and time-course profile of FVIII activity after dosing with SB-525 (PF-07055480)
Want to learn more about this trial?
Request More InfoInterventions
SB-525 (PF-07055480)BIOLOGICAL
Single dose of investigational product SB-525 (PF-07055480)
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | United States |
| City of Hope Medical Center | Duarte | California | United States |
| Midtown Ambulatory Care Center | Sacramento | California | United States |
| UC Davis Ambulatory Care Clinic | Sacramento | California | United States |
| UC Davis Comprehensive Cancer Center | Sacramento | California | United States |
| UC Davis CTSC Clinical Research Center | Sacramento | California | United States |
| UC Davis Hemophilia Treatment Center | Sacramento | California | United States |
| UC Davis Investigational Drug Services Pharmacy | Sacramento | California | United States |
| UC Davis Medical Center | Sacramento | California | United States |
| University of California, San Francisco - Investigational Drug Service (IDS) Pharmacy | San Francisco | California | United States |
| University of California, San Francisco - Outpatient Hematology Clinic | San Francisco | California | United States |
| University of California, San Francisco -Moffitt Hospital | San Francisco | California | United States |
| University Of Miami Hospital and Clinics/Sylvester Comprehensive Cancer Center | Miami | Florida | United States |
| USF Health Morsani Center For Advanced Healthcare | Tampa | Florida | United States |
| Emory University School of Medicine | Atlanta | Georgia | United States |
| Hemophilia Center of Western PA | Pittsburgh | Pennsylvania | United States |
| UPMC Montefiore Clinical and Translational Research Center | Pittsburgh | Pennsylvania | United States |
| UPMC, Investigational Drug Service | Pittsburgh | Pennsylvania | United States |
| Vanderbilt University Medical Center Clinical Research Center | Nashville | Tennessee | United States |
| Vanderbilt Hemostasis Treatment Clinic | Nashville | Tennessee | United States |
| Vanderbilt Hemostasis-Thrombosis Clinic | Nashville | Tennessee | United States |
| Washington Institute for Coagulation | Seattle | Washington | United States |